title: Schizophrenia treatment guidelines in the United States.
abstract: BACKGROUND
  The development of algorithms and guidelines in medicine is widespread. There are six major guidelines used and/or influencing the treatment of schizophrenia in the United States. The impact of these guidelines on clinical practice is difficult to evaluate. Many studies to date show poor adherence to schizophrenia guideline recommendations.
  
  
  OBJECTIVE
  The purpose of this article is to discuss the rationale for use of guidelines/algorithms in medicine, the importance of schizophrenia guidelines, barriers to using guidelines, and to review key aspects of schizophrenia guidelines most commonly used in the United States.
  
  
  RESULTS
  Schizophrenia guidelines/algorithms differ somewhat in scope, focus, goals, and recommendations. Each guideline/algorithm has its utility in clinical practice.
authors: Department of Psychiatry, The University of Texas Health Science Center at San Antonio South Texas Veterans Health Care System, San Antonio, TX, USA. troy.moore3@va.gov
authors: Troy A
authors: TA
authors: Moore
mesh_terms: D000465:Algorithms; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001291:Attitude of Health Personnel; D003131:Combined Modality Therapy; D004282:Documentation; D057915:Drug Substitution; D019317:Evidence-Based Medicine / Q000458:organization & administration*; D019983:Guideline Adherence / Q000458:organization & administration; D006801:Humans; D017410:Practice Guidelines as Topic; D012008:Recurrence; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome; D014481:United States
chemical_list: D014150:Antipsychotic Agents